Achieve Life Sciences Debt to Equity

Achieve Life Sciences (QUIT) currently reports a debt-to-equity ratio of -1.02. That is below the Technology sector average of 0.47. Use the charts on this page to explore Achieve Life Sciences's debt-to-equity ratio history and peer comparisons.

Achieve Life Sciences's debt-to-equity ratio of -1.02 is lower than the Technology sector average of 0.47. That is roughly 315.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The debt-to-equity ratio is a valuation multiple that relates Achieve Life Sciences's market price to a fundamental measure such as earnings, sales, or book value. At -1.02, QUIT can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current debt-to-equity ratio of -1.02, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 0.47. From there, open related valuation or income-statement pages for Achieve Life Sciences, and consider following QUIT for alerts when major investors trade the stock.

Achieve Life Sciences is classified in the Technology sector. On debt-to-equity ratio, it currently shows -1.02 versus a sector average near 0.47. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing QUIT with unrelated industries.